EDGAR Filing Documents for 0001193125-07-057204

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-07-057204

Filing Date

2007-03-16

Accepted

2007-03-16 16:53:12

Documents

Period of Report

2006-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1285748
2	THIRD AMENDMENT TO SUBLEASE AGREEMENT	dex106.htm	EX-10.6	32067
3	AGREEMENT TO MODIFY THE CORPORATION'S COMPENSATION ARRANGEMENT	dex1042.htm	EX-10.42	7119
4	AMENDMENT NO. 1 TO THE AGREEMENT TO MODIFY THE CORPORATION'S COMPENSATION ARR.	dex1043.htm	EX-10.43	4567
5	AGREEMENT TO BONUS PAYMENT AND CONTINGENT BONUS PAYMENT	dex1044.htm	EX-10.44	4250
6	STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES	dex121.htm	EX-12.1	16624
7	SUBSIDIARIES OF THE REGISTRANT	dex211.htm	EX-21.1	939
8	CONSENT OF STONEFIELD JOSEPHSON, INC.	dex231.htm	EX-23.1	1702
9	CONSENT OF GRANT THORNTON LLP	dex232.htm	EX-23.2	2058
10	CERTIFICATION OF CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	7424
11	CERTIFICATION OF CHIEF FINANCIAL OFFICER	dex312.htm	EX-31.2	7757
12	CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER	dex32.htm	EX-32	7500
13	GRAPHIC	g25468g41f21.jpg	GRAPHIC	66390
	Complete submission text file	0001193125-07-057204.txt		1470790

Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119

Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)